AZIN1 and cancer: Compared to wild type AZIN1, AZIN1S367G has greater antizyme binding, inhibiting antizyme-mediated degradation of ODC and CCND1, thereby facilitating entry into cell cycle and increasing the malignancy of the cancer cell [36].